I-Dibikor - imiyalo yokusebenzisa, ama-analogues, intengo, izibuyekezo

Ukutholwa kwe-taurine

Ingxenye esebenzayo ye-Dibicore yahlukaniswa okokuqala ngasekupheleni kwekhulu le-19 ukusuka kwi-bile yenkunzi, maqondana negama layo, ngoba "taurus" ihunyushwa isuka esiLatini ngokuthi "inkunzi". Ucwaningo luthole ukuthi ingxenye iyakwazi ukulawula i-calcium kumaseli e-myocardial.

Kuqala, akekho noyedwa owakhaphela ukubaluleka okukhethekile kule nto kuze kwavela ukuthi emzimbeni wamakati awakhiwa nhlobo, futhi ngaphandle kokudla, kuthuthukisa ubumpumputhe ezilwaneni futhi kwephula imininingwane yemisipha yenhliziyo. Kusukela kulowo mzuzu, ososayensi baqala ukutadisha ngokucophelela isenzo nezakhiwo ze-taurine.

Ukwakheka nefomu lokukhishwa kweDibicore

I-Dibicor ikhiqizwa ngohlobo lwamaphilisi okusetshenziswa kwangaphakathi, okuqukethwe kwe-taurine kuwo kungama-500 mg no-250 mg.

Izici ezisizayo zomuthi:

• i-microcrystalline cellulose;
• i-gelatin;
• i-calcium stearate;
• I-Aerosil (synthetic silicon dioxide);
• isitashi samazambane.

I-Dibicor ithengiswa kumathebhulethi angama-60 kwiphakeji elilodwa.

Umkhiqizi: Inkampani yaseRussia "PIK-PHARMA LLC"

Isenzo se-Pharmacological

Ukwehla kukashukela wegazi kushukela kwenzeka cishe emavikini angama-2-3 ngemuva kokuqala kwenkambo yokwelashwa. I-Dibicor nayo inciphisa kakhulu ukugcwala kwama-triglycerides ne-cholesterol.

Ukusetshenziswa kwe-taurine ekuhlanganisweni kokwelashwa ezigulini ezinezifo zenhliziyo ezahlukahlukene kunomthelela omuhle esimweni semisipha yenhliziyo. Ivimbela ukuzuma emijikelezweni emincane nemikhulu yokujikeleza kwegazi, maqondana nakho lapho kukhona ukuncipha kwengcindezi ye-diastolic ye-intracardiac futhi kukhona ukwanda kwe-contractility ye-myocardium.

Ezinye izakhiwo ezinhle zomuthi:

• I-Dibicor ngokwejwayelekile i-synthesis ye-epinephrine ne-gamma-aminobutyric acid, enomphumela omuhle ekusebenzeni kohlelo lwezinzwa. Inomphumela we-antistress.
• Umuthi udambisa kancane umfutho wegazi kubantu abane-hypertension eyinhloko, kuyilapho awunawo nomthelela kwizibalo zawo ezigulini ezinama-inhliziyo ne-hypotension.
• Ilawula izinqubo ze-metabolic emzimbeni (ikakhulukazi kwesibindi nenhliziyo). Ngezifo ze-hepatic zesikhathi eside, zandisa ukunikezwa kwegazi esitho.
• I-Dibicor yehlisa umphumela onobuthi wezidakamizwa ze-antifungal esibindini.
• Kwenza ukungathathi hlangothi kwezakhi zakwamanye amazwe ezinobuthi.
• Kuthuthukisa amandla emzimbeni futhi kwandisa amandla okusebenza.
• Ngokuvuma izifundo okuthatha isikhathi esingaphezu kwezinyanga eziyisithupha, ukwanda kwe-microcirculation ku-retina kuyaphawulwa.
• Kuthatha ingxenye esebenzayo emgodini wokuphefumula we-mitochondrial, i-Dibicor iyakwazi ukulungisa izinqubo ze-oxidative, inezindawo ze-antioxidant.
• Iguqula ukucindezela kwe-osmotic, futhi ilungisa okungcono izinqubo ze-metabolic ze-potassium ne-calcium endaweni yeseli.

I-Dibikor - izinkomba zokusetshenziswa

• Isifo sikashukela i-mellitus uhlobo I no-II, kufaka phakathi isilinganiso esikhuphuka kancane se-lipids egazini.
• Ukusetshenziswa kwe-glycosides yenhliziyo emithanjeni enobuthi.
• Izinkinga ezivela enhliziyweni nemithambo yegazi yemvelaphi ehlukahlukene.
• Ukugcina umsebenzi wesibindi ezigulini ezinqunyelwe ama-antifungal agents.

Kunobufakazi bokuthi i-Dibikor ingasetshenziswa njengendlela yokunciphisa umzimba. Kodwa ngokwayo, ayishisi amakhilogremu angeziwe, ngaphandle kokudla okuphansi kwe-carb nokuqeqeshwa okujwayelekile, ngeke kube nomphumela. Umuthi osuselwa kwe-taurine usebenza kanjena:

1. I-Dibicor isheshisa i-catabolism futhi isiza ukwehlisa amanoni omzimba.
2. I-Lowers cholesterol kanye nokugxila kwe-triglyceride.
3. Kwandisa amandla okusebenza nokukhuthazela ngokomzimba.

Kulokhu, uDibikor kufanele aqokwe ngudokotela ozobheka isimo sempilo yabantu.

Contraindication kanye nemiphumela emibi

Ithuluzi livinjelwe ukusetshenziswa ngabantu abaneminyaka engaphansi kweningi, njengoba azikho izivivinyo ezifanele ezenziwayo zokuqinisekisa ukusebenza nokuphepha kuleli banga. Ukwephula okuqondile kukhula ngokwengeziwe ezingxenyeni zomuthi.

Imiyalo yokusebenzisa, umthamo

• Uma kwenzeka ng Uhlobo lwesifo sikashukela i-mellitus - 500 mg kabili ngosuku, inkambo yokwelashwa isukela ezinyangeni ezintathu kuya ezinyangeni eziyisithupha,isetshenziswa nge-insulin.
• Ngokwesifo sikashukela sohlobo II, umthamo we-Dibicore uyefana nowami, ungasetshenziswa njenge-monotherapy noma uhlanganiswe nezinye izidakamizwa ezinciphisa ushukela ekuphatheni ngomlomo. Kwabashukela abane-cholesterol ephezulu, umthamo ungama-500 mg izikhathi ezi-2 ngosuku. Isikhathi sokwelashwa sinqunywa ngudokotela.
• Uma kwenzeka ubuthi bunamanani amaningi we-inhliziyo glycosides, kudingeka okungenani i-750 mg ye-Dibicor ngosuku.
• Uma kukhona ukwephulwa komsebenzi wenhliziyo, amaphilisi athathwa ngomlomo ngesilinganiso esingu-250-500 mg kabili ngosuku imizuzu engama-20-30 ngaphambi kokudla. Inkambo yokwelashwa okujwayelekile kumaviki ama-4. Uma kudingeka, umthamo ungakhushulwa ufike kuma-3000 mg ngosuku.
• Ngokuvimbela imiphumela elimazayo yabaphatheli be-antifungal esibindini, i-Dibicor inconyelwa ukuthatha ama-500 mg izikhathi ezi-2 ngosuku ngosuku lokudla kwabo.

Njengoba i-Dibicor ikhiqizwa ekugxilweni okubili, kubaqalayo kungcono ukuthatha i-250 mg ukusungula umthamo ongaguquki. Ngaphezu kwalokho, ukwahlukaniswa kwamathebhulethi angama-500 mg akuvunyelwe njalo, ngoba ingxenye eyodwa ingaqukatha ngaphansi kwama-250 mg, kanti enye, ngokulandelana, ngaphezulu, okuthinta kabi umzimba ngesikhathi sokuphathwa kwenkambo. Amacwecwe anconywe ukuphuza isigamu seglasi yamanzi ahlanzekile ekushiseni kwegumbi.

Ngemuva kokufaka i-Dibikor ngaphakathi, ingena ngokushesha ekujikelezeni kwe-systemic, okuhlushwa kufinyelela inani layo eliphezulu ngemuva kwengxenye yehora. Umuthi ukhishwa emzimbeni ngaphakathi kwamahora angama-24 ngomchamo.

Imiyalo ekhethekile nokusebenzisana kwezidakamizwa

• Ngesikhathi sokuphathwa kwe-Dibicor, kunconyelwa ukunciphisa umthamo we-digoxin ngesigamu, kepha lesi sibalo sincike ekuzwelweni kwesiguli esithile kubo futhi umthamo ulungiswa uchwepheshe. Okufanayo kusebenza kumalungiselelo eqembu le-calcium antagonist.
• Akukho zifundo ezenziwayo ngokuphepha komama abakhulelwe nabesifazane asebekhulelwe, akwaziwa ukuthi umuthi uthinta kanjani ingane kanye nomzimba wosana olusanda kuzalwa, ngakho-ke kunconyelwa ukwenqaba ukuthatha ngalesi sikhathi sesikhathi.
• I-Dibikor ayikuthinti ukusabela kwe-psychomotor, ikuvumela ukuthi wenze izinhlobo ezahlukahlukene zomsebenzi ezihambisana nokusatshalaliswa okwandayo. Akuthinti amandla okushayela izimoto nokulawula izindlela eziyinkimbinkimbi.
• Akukho datha ekuxhumaneni okungalungile kwesidakamizwa nezinye izidakamizwa. Kepha nokho, kufanele kuqashelwe ngokusetshenziswa okukodwa nge-digoxin nokunye, njengoba kukhona ukwanda komphumela we-inotropic (ukukhuphuka kwenhliziyo).

Izimo zokugcina nokuphila eshalofini

Ukuze ulondoloze izindawo ezinhle zomuthi kuze kube kuphela isikhathi sokuphelelwa kwaso, kufanele zigcinwe endaweni eyomile, zivikelwe elangeni elikhanyayo, emazingeni okushisa ebangeni ukusuka ku-15 ° C kuya ku-25 ° C. Kungcono ukugcina i-Dibikor ephakeme futhi ngemidwebo ekhonjiwe, ekhoneni kungafinyeleleki ezinganeni ezincane.

Impilo yeshelufu ayidluli iminyaka emi-3 ukusuka ngosuku lokukhiqizwa, ngemuva kwalokho umuthi ungaphansi kokulahlwa.

Intengo

Amanani aphakathi kwe-Dibikor:

Ama-analog kaDibikor

Ngo-2014, iCardioActive Taurine ene-500 mg yabhaliswa. Okwamanje, lokhu kuphela i-analogue ye-Dibicor kumathebulethi, okuyisidakamizwa. Amatafula asele kanye namaphilisi asele nalokhu kungukudla kokudla kokudla.

Kunezindlela ezahlukahlukene zemithamo ngalesi sithako esisebenzayo, zisetshenziselwa kakhulu amehlo:

• Amaconsi e-Ophthalmic: iTaufon, Taurine, Igrel, Oftofon taurine.
• Isixazululo sokuphathwa kwe-intraocular (umjovo we-conjunctival) Taurine.

Izidakamizwa ezihlanganisiwe zikhiqizwa nalokhu, isibonelo, ama-suppositories i-Genferon ne-Genferon Light. Kumalungiselelo angenhla, idlala indima ye-immunomodulator, inyusa umphumela wokwelapha wezinto ezisebenzayo, futhi inciphise ukuthuthukiswa kwezinqubo ezingejwayelekile ngaphakathi kwamangqamuzana.

Ukubuyekezwa

I-Eugene. Udokotela we-endocrinologist wangincoma ukuthi ngithathe i-dibicor, ngine-Type 2 sikashukela mellitus. Umuthi muhle, uzizwa ungcono ngawo. Angiyiphuzi njalo, ngezikhathi ezithile - ushukela awugxumi, ngaphakathi kwemikhawulo ejwayelekile, ngilandela ukudla.

Anastasia Bengihlala nesifo sikashukela sohlobo 2 isikhathi eside, kulula kimi uqobo ne-dibicor ukugcina izinga le-glucose lilijwayelekile. Ngilandela ukudla, ngisho ne-cholesterol inciphile kancane. Uqale ukucindezela uDibikor ngemuva kokufunda ukubukeza okuningi okuhle.

Umbono we-Diabetesic on Dibicore:

Ubufakazi obuvela kwabasebenza

Isazi se-Endocrinologist uYaroslav Vladimirovich. I-Dibicor isidakamizwa esuselwe ku-taurine; ukusebenza kwayo kufakazelwe izifundo eziningi. Isebenzisa ushukela, njengoba kwehlisa ushukela wegazi kanye ne-cholesterol. Kepha ungakhohlwa ukuthi leli yithuluzi elisizayo! Ngeke kube khona isimangaliso! Uma wenqaba ukwelashwa okuyinhloko: ukudla, izidakamizwa ezinciphisa ushukela noma i-insulin, khona-ke izinga likashukela lizokhuphuka ngokushesha.

UDmitry Gennadievich. E-Russia, odokotela bavame ukunquma i-dibicor kanye namalungiselelo we-sulfonylurea noma ama-metformin; e-Ukraine, ama-endocrinologists yonke indawo anquma i-Dialipon (i-alpha lipoic acid).